PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma
Clinical trial NCT03850522 · TERMINATED
Trial details
- NCT number
- NCT03850522
- Sponsor
- Lene Meldgaard Knudsen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-18
- Primary completion
- 2021-03-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.